Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR5A | P47898 | 4/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | DRD4 | P21917 | 1/20 | 0.39 |
| ▸ | HTR1D | P28221 | 1/20 | 0.39 |
| ▸ | HTR1B | P28222 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | HTR7 | P34969 | 1/20 | 0.39 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 1/20 | 0.39 |
| ▸ | HTR2B | P41595 | 1/20 | 0.39 |
| ▸ | HTR6 | P50406 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | BRS3 | P32247 | 1/20 | 0.35 |
| ▸ | PTGES | O14684 | 1/20 | 0.35 |
| ▸ | CDK1 | P06493 | 1/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.34 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.34 |
| ▸ | SLC2A1 | P11166 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13137044 | 0.94 | CDK1 (0.38) | HTR5AEPHX1PTGESCDK1S1PR1 | |
| Trifluoroacetic Acid SCHEMBL3050685 | 0.90 | HTR5A (0.41) | HTR5AHTR1ADRD2DRD4HTR1D | |
| Trifluoroacetic Acid SCHEMBL3046203 | 0.87 | HTR5A (0.46) | HTR5AHTR1ADRD2DRD4HTR1D | |
| Trifluoroacetic Acid SCHEMBL3044733 | 0.85 | HTR5A (0.40) | HTR5AHTR1ADRD2DRD4HTR1D | |
| Trifluoroacetic Acid SCHEMBL3048446 | 0.83 | HTR5A (0.41) | HTR5AHTR1ADRD2DRD4HTR1D | |
| Trifluoroacetic Acid SCHEMBL3042074 | 0.82 | HDAC6 (0.39) | HTR5AHTR1ADRD2DRD4HTR1D | |
| Trifluoroacetic Acid SCHEMBL3044503 | 0.81 | HTR5A (0.44) | HTR5AHTR1ADRD2DRD4HTR1D | |
| SCHEMBL13137055 | 0.81 | SIGMAR1 (0.37) | EPHX1SIGMAR1PIK3CAMTORGSK3A | |
| SCHEMBL13137200 | 0.81 | SIGMAR1 (0.37) | DRD4DRD3EPHX1BRS3SIGMAR1 | |
| SCHEMBL13137049 | 0.81 | SIGMAR1 (0.37) | EPHX1BRS3SIGMAR1PIK3CAMTOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100222345-A1 | NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS | SMITHKLINE BEECHAM CORPORATION | 2010-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222345-A1 | NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS | OPRL1, OPRM1, OPRK1 | HTR5A 190/4885HTR1A 197/4885DRD2 140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.